Skip to main content
profile image
Selected Works of Philip Mease, MD
Presentation
The Efficacy of Certolizumab Pegol over 4 Years in Psoriatic Arthritis Patients With and Without Concomitant Use of DMARDs. Irish Society for Rheumatology Autumn Meeting, ISR 2017, Galway, Ireland, Sept 2017.
Irish Society for Rheumatology Autumn Meeting, ISR 2017 (2017)
  • Philip Mease, Providence St. Joseph Health
  • et.al.
Link
Disciplines
Publication Date
September, 2017
Citation Information
Philip Mease and et.al.. "The Efficacy of Certolizumab Pegol over 4 Years in Psoriatic Arthritis Patients With and Without Concomitant Use of DMARDs. Irish Society for Rheumatology Autumn Meeting, ISR 2017, Galway, Ireland, Sept 2017." Irish Society for Rheumatology Autumn Meeting, ISR 2017 (2017)
Available at: http://works.bepress.com/philip-mease/188/